Results 161 to 170 of about 1,141,931 (248)

Hybrid regulatory T cells: camouflaged architects of tumor immunity. [PDF]

Front Immunol
Azimnasab-Sorkhabi P, Soltani-Asl M, Kfoury Junior JR, Ansa-Addo EA.   +3 more
europepmc   +1 more source

Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course [PDF]

, 2011
Toshiaki Hanafusa, Hiroaki Azukizawa, Shun Kitaba, Hiroyuki Murota, Noriko Umegaki, Mika Terao, Shigetoshi Sano, Tomoyuki Nakagiri, Meinoshin Okumura, Ichiro Katayama   +9 more
openalex   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Regulatory T-cells in Reproductive Medicine: Implications for Endometriosis-Associated Infertility and Implantation Immunity. [PDF]

Cureus
Taguchi S, Hayashi T.
europepmc   +1 more source

Regulatory T-Cell Therapy for Graft-versus-host Disease.

, 2016
Jessica Heinrichs, David Bastian, Anandharaman Veerapathran, Claudio Anasetti, Brain Betts, Xue‐Zhong Yu   +5 more
openalex   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential. [PDF]

Signal Transduct Target Ther
Wang L, Liang Y, Zhao C, Ma P, Zeng S, Ju D, Zhao M, Yu M, Shi Y.   +8 more
europepmc   +1 more source

Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficacy in mouse autoimmune models [PDF]

J. Matusik Robert, Manon Feuillolay, María de Temple-Llavero, Reginald Florian Akossi, Vanessa Mhanna, Mustapha Cheraï, Gwladys Fourcade, Frédéric Charlotte, Nicolas Tchitchek, Mi Tian, Ben Youngblood, Thomas Vazquez, Michèlle Rosenzwajg, David Klatzmann   +13 more
openalex   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Immunomodulation of UVB-induced regulatory T cells prevents the establishment of squamous cell carcinoma. [PDF]

J Immunother Cancer
Anwaar S, Ashraf A, Jahfali S, Yunis J, Gonzalez Cruz JL, Wells JW.   +5 more
europepmc   +1 more source